Wagner JA - Search Results

1

Effects of laropiprant, a selective prostaglandin D(2) receptor 1 antagonist, on the pharmacokinetics of rosiglitazone.

Schwartz JI, Stroh M, Gao B, Liu F, Rosko K, Zajic S, Meehan AJ, Ruckle J, Lai E, Wagner JA. Schwartz JI, et al. Among authors: wagner ja. Cardiovasc Ther. 2009 Winter;27(4):239-45. doi: 10.1111/j.1755-5922.2009.00104.x. Cardiovasc Ther. 2009. PMID: 19903187 Free article. Clinical Trial.

2

Influence of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the pharmacokinetics and pharmacodynamics of warfarin.

Schwartz JI, Liu F, Stroh M, Gipson A, Johnson-Levonas AO, Lasseter KC, Lai E, Wagner JA. Schwartz JI, et al. Among authors: wagner ja. Am J Ther. 2009 May-Jun;16(3):215-23. doi: 10.1097/MJT.0b013e31818f9c68. Am J Ther. 2009. PMID: 19454860 Clinical Trial.

3

Effect of laropiprant, a PGD2 receptor 1 antagonist, on estradiol and norgestimate pharmacokinetics after oral contraceptive administration in women.

Schwartz JI, Liu F, Wang YH, Pramanik B, Johnson-Levonas AO, Gutierrez MJ, Lai E, Wagner JA. Schwartz JI, et al. Among authors: wagner ja. Am J Ther. 2009 Nov-Dec;16(6):487-95. doi: 10.1097/MJT.0b013e3181985130. Am J Ther. 2009. PMID: 19940609 Clinical Trial.

4

Effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the steady-state pharmacokinetics of digoxin in healthy adult subjects.

Liu F, Vessey L, Wenning L, Connolly S, Buckland M, Johnson-Levonas AO, Denker A, Wagner JA, Lai E. Liu F, et al. Among authors: wagner ja. J Clin Pharmacol. 2010 Jul;50(7):823-8. doi: 10.1177/0091270009356571. Epub 2010 Mar 2. J Clin Pharmacol. 2010. PMID: 20197486 Clinical Trial.

5

Effects of multiple doses of clarithromycin on the pharmacokinetics of laropiprant in healthy subjects.

Wang YH, Schwartz JI, Luo WL, Jumes P, Desai R, Wenning LA, Wagner JA, Lai E. Wang YH, et al. Among authors: wagner ja. Cardiovasc Ther. 2011 Apr;29(2):140-5. doi: 10.1111/j.1755-5922.2009.00129.x. Cardiovasc Ther. 2011. PMID: 20337634 Free article. Clinical Trial.

6

Pharmacokinetics of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, in patients with moderate hepatic impairment.

Wang YH, Liu F, Luk JA, Nirula A, Johnson-Levonas AO, Lasseter KC, Marbury TC, Lunde NM, Wagner JA, Lai E. Wang YH, et al. Among authors: wagner ja. J Clin Pharmacol. 2011 Mar;51(3):406-12. doi: 10.1177/0091270010369240. Epub 2010 May 19. J Clin Pharmacol. 2011. PMID: 20484612 Clinical Trial.

7

The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.

Dallob A, Luo WL, Luk JM, Ratcliffe L, Johnson-Levonas AO, Schwartz JI, Dishy V, Kraft WK, De Hoon JN, Van Hecken A, De Lepeleire I, Radziszewski W, Wagner JA, Lai E. Dallob A, et al. Among authors: wagner ja. Platelets. 2011;22(7):495-503. doi: 10.3109/09537104.2011.565433. Epub 2011 Apr 28. Platelets. 2011. PMID: 21526889 Free article. Clinical Trial.

8

Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1.

Lai E, De Lepeleire I, Crumley TM, Liu F, Wenning LA, Michiels N, Vets E, O'Neill G, Wagner JA, Gottesdiener K. Lai E, et al. Among authors: wagner ja. Clin Pharmacol Ther. 2007 Jun;81(6):849-57. doi: 10.1038/sj.clpt.6100180. Epub 2007 Mar 28. Clin Pharmacol Ther. 2007. PMID: 17392721 Clinical Trial.

9

Pharmacokinetics, pharmacodynamics, and safety of a prostaglandin D2 receptor antagonist.

Lai E, Wenning LA, Crumley TM, De Lepeleire I, Liu F, de Hoon JN, Van Hecken A, Depré M, Hilliard D, Greenberg H, O'Neill G, Metters K, Gottesdiener KG, Wagner JA. Lai E, et al. Among authors: wagner ja. Clin Pharmacol Ther. 2008 Jun;83(6):840-7. doi: 10.1038/sj.clpt.6100345. Epub 2007 Sep 19. Clin Pharmacol Ther. 2008. PMID: 17882161 Clinical Trial.

10

Pharmacokinetics of laropiprant and glucuronide metabolite in patients with severe renal insufficiency.

Stroh M, Wenning L, Luo WL, Desai R, Bi S, Keshavarz S, Lazarus N, Lunde NM, Smith WB, Schwartz M, Stone J, Wagner J, Lai E, Dishy V. Stroh M, et al. Am J Ther. 2009 Sep-Oct;16(5):379-84. doi: 10.1097/MJT.0b013e318197c59d. Am J Ther. 2009. PMID: 19433974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

554 results

Search Page

Filters